World's second malaria vaccine gets WHO approval: Serum Institute of India

Updated: Oct 2 2023 10:39PM

New Delhi, Oct 2 (PTI) Serum Institute of India on Monday said the World Health Organisation (WHO) has approved a malaria vaccine, paving the way for the global roll-out of the world's second such vaccine.

The recommendation is based on pre-clinical and clinical trial data which showed good safety and high efficacy in four countries, at sites with both seasonal and perennial malaria transmission, making it the world's second-ever WHO recommended vaccine for preventing malaria in children, SII said in a statement.

The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII), leveraging Novavax's adjuvant technology, has been recommended for use by the WHO.

Press Trust Of India (PTI) is India's premier news agency, with a reach as vast as the Indian Railways'. It employs nearly 400 journalists and 500 stringers to cover almost every city and small town in India. Collectively, our journalists put out more than 1,000 stories and 250 photographs including graphics every day to feed the appetite of the diverse subscribers, who include the mainstream media, the specialized presses, research groups, companies, and government and non-governmental organizations.

General Access

Add On Customer Packages

The Press Trust Of India Ltd.

PTI building 4, Parliament Street, New Delhi-110 001

© PTI 2021, All Right Reserved

Designed by: 4c Plus